Fisher & Paykel HealthcareASX:FPH +0.13%88 FCF Yield % is 2.07 as of Jun. 26, 2026, which is 51% above its 10-year median of 1.37. GuruFocus rates ASX:FPH with a GF Score™ of 88/100 and a GF Value™ of A$36.31 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks better than 65.26% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Fisher & Paykel Healthcare's FCF Yield % or its related term are showing as below:
ASX:FPH'
s FCF Yield % Range Over the Past 10 Years
Min: 0.17 Med: 1.37 Max: 3.11
Current: 2.07
During the past 13 years, the highest FCF Yield % of Fisher & Paykel Healthcare was 3.11%. The lowest was 0.17%. And the median was 1.37%.
ASX:FPH's FCF Yield % is ranked better than 65.26% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.38
vs ASX:FPH: 2.07
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Fisher & Paykel Healthcare FCF Yield % Related Terms
Fisher & Paykel Healthcare FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:FPH vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (ASX:FPH) has a FCF Yield % of 2.07 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Fisher & Paykel Healthcare and its competitors. This is 51% above median its historical median of 1.37. Over the past decade, Fisher & Paykel Healthcare's FCF Yield % has ranged from 0.17 to 3.11. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #297 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 34.7%.
Is Fisher & Paykel Healthcare's FCF Yield % too high?
Fisher & Paykel Healthcare's current FCF Yield % of 2.07 is 51% above median its 10-year median of 1.37. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 3.11. Based on the distribution chart, Fisher & Paykel Healthcare ranks #297 out of 855 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 88/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #297 out of 855 companies for FCF Yield %. This puts Fisher & Paykel Healthcare in the upper half of its industry. Historically, Fisher & Paykel Healthcare's own FCF Yield % has ranged from 0.17 to 3.11 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current FCF Yield % is 2.07, which is 51% above median its own 10-year median of 1.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is A$36.31, compared to a current price of A$31.57 — trading 13.1% below its estimated fair value. The current FCF Yield % is 2.07, which is 51% above median its 10-year median of 1.37. Fisher & Paykel Healthcare's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current FCF Yield % is 2.07 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of A$31.57 is trading 13.1% below its estimated GF Value™ of A$36.31.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:FPH:
FCF Yield %: 2.07 (51% above median its 10-year median of 1.37)
GF Value™: A$36.31 vs. price of A$31.57 (13.1% below fair value)
No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
88GF Score
Get the complete analysis for ASX:FPH
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:FPH has been successfully added to your 
